Gene therapy (Codexis/Crosswalk Therapeutics)

N/A

Report date: 2025/05/22 17:22:53

Base Information

Drug NameGene therapy (Codexis/Crosswalk Therapeutics)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsFabry Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCodexis Inc
China Registration ClassN/A

Develop Information

Active CompaniesCrosswalk Therapeutics IncCodexis Inc
Inactive CompaniesN/A
Active IndicationsFabry Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A